These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11979839)

  • 21. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
    Orv Hetil; 2006 Mar; 147(10):435-9. PubMed ID: 16573172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
    Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
    Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K
    J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Peptic ulcer and gastritis in the time of Helicobacter pylori].
    Ann Gastroenterol Hepatol (Paris); 1996; 32(1):25-34. PubMed ID: 8669805
    [No Abstract]   [Full Text] [Related]  

  • 27. The health economics of Helicobacter pylori infection.
    Moayyedi P
    Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori and peptic ulcer disease.
    Feldman M; Peterson WL
    West J Med; 1993 Nov; 159(5):555-9. PubMed ID: 8279151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome.
    Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M
    Aliment Pharmacol Ther; 2005 Apr; 21(8):1047-53. PubMed ID: 15813841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Peptic ulcer recurrence after successful eradication of Helicobacter pylori--clinical characteristics and management].
    Watanabe T; Higuchi K; Tominaga K; Fujiwara Y; Arakawa T
    Nihon Rinsho; 2004 Mar; 62(3):495-8. PubMed ID: 15038093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Eradication of Helicobacter pylori in Japan].
    Kamimoto H; Fukuda Y; Tamura K; Shimoyama T
    Nihon Rinsho; 1999 Jun; 57(6):1435-41. PubMed ID: 10391015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role for Helicobacter pylori infection in intractable and recurrent ulcer].
    Kubota T; Ito A; Shiota K; Fujioka T
    Nihon Rinsho; 1993 Dec; 51(12):3221-6. PubMed ID: 8283637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of H. pylori infection: the reality.
    Vakil N
    Yale J Biol Med; 1998; 71(2):119-24. PubMed ID: 10378357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of peptic ulcer disease: is Helicobacter pylori a consideration?
    Pajares JM; Carballo F; Blanco M
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():40-4. PubMed ID: 1349551
    [No Abstract]   [Full Text] [Related]  

  • 35. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of Helicobacter pylori in gastroduodenal disease.
    Wang KK
    Compr Ther; 1991 Sep; 17(9):35-8. PubMed ID: 1769198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eradication of Helicobacter pylori followed by reinfection.
    Tonokatsu Y; Fukuda Y; Tsujiai T; Tamura K; Shimoyama T
    J Gastroenterol; 1996 Nov; 31 Suppl 9():75-6. PubMed ID: 8959526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of Helicobacter pylori eradication therapy at a company occupational health clinic in Japan.
    Yamasaki T
    J UOEH; 2002 Jun; 24(2):161-76. PubMed ID: 12066584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A new clinical strategy in peptic ulcer disease. Suggestions for the elimination of Helicobacter pylori].
    Unge P; Ekström P
    Lakartidningen; 1994 May; 91(19):1925-32. PubMed ID: 8189937
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical description of peptic ulcer--National Health Insurance coverage of H. pylori eradication therapy].
    Ito M
    Nihon Naika Gakkai Zasshi; 2001 Sep; 90(9):1897-903. PubMed ID: 11681078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.